CTEV

4 - Claritev Corp (0001793229) (Issuer)

8-K - Claritev Corp (0001793229) (Filer)

MCLEAN, Va., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data, and insights company, today announced that its Board of Directors ("Board") has appointed Jennifer (Jenni) Main as a director, effective today, filling a newly created directorship on the Board. Main brings more than three decades of leadership experience across healthcare, technology, government, and finance. She currently serves as Chief Financial Officer of RealMDai (dba Certuma) and Overture Life, roles she has held since March 2026. Previously, she served as Chief Financial Officer and Chief Operating Officer of Amalgam Rx from 2021 to 2026. "Jenni brings

MCLEAN, Va., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent, and fair for all, announced today that it will release its third quarter fiscal year 2026 financial results prior to market open on Monday, November 9, 2026, and hold a conference call at 8:00 am Eastern Time. A live webcast of the conference call can be accessed through the Investor Relations section of the Company’s website at investors.claritev.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. The

SCHEDULE 13G/A - Claritev Corp (0001793229) (Subject)

4 - Claritev Corp (0001793229) (Issuer)

Claritev will support General Dynamics Information Technology by providing the Nationwide Provider Network for World Trade Center Responders and Survivors Claritev Corporation (NYSE:CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center (WTC) Health Program. The WTC Health Program is a limited federal health care program established under the James Zadroga 9/11 Health and Compensation Act of 2010 (Extended in 2015). It provides nationwide medical monitoring and treatment to responders and survivors of the even

Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data, and insights company, today announced the publication of its 2025 Corporate Responsibility Report. The report highlights progress across Claritev’s corporate responsibility priorities, including responsible AI, employee engagement, community impact, and sustainable operations. Throughout 2025, the Company remained focused on advancing transparency and affordability across healthcare while reinforcing the governance, talent, and operating capabilities that support the business. "At Claritev, corporate responsibility is reflected in how we design our solutions, govern our data, support our peopl

4 - Claritev Corp (0001793229) (Issuer)

3 - Claritev Corp (0001793229) (Issuer)

8-K - Claritev Corp (0001793229) (Filer)

Board gains deep technology and innovation expertise to support Claritev’s tech-driven growth strategy Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data, and insights company, today announced that its Board of Directors ("Board") has appointed Ben Letham as a director, effective September 14, 2026, to fill a vacancy on the Board. Letham’s extensive experience in artificial intelligence (AI) will enhance the Board’s depth of expertise and support the Company’s long-term strategic objectives. Letham is a leader in AI and optimization systems, with particular depth in large-scale digital experimentation and applied data analysis. He has co-authored more th

4 - Claritev Corp (0001793229) (Issuer)

Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data, and insights company, today announced that members of its management team will meet with investors at the following events in September 2026: Wells Fargo 21st Annual Healthcare Conference – Wednesday, September 9, 2026, at the Encore Boston Harbor – one-on-one meetings J.P. Morgan 4th Annual Healthcare Credit Conference - Thursday, September 10, 2026, at The Joseph Nashville – small group meetings Morgan Stanley 24th Annual Global Healthcare Conference – Tuesday, September 15, 2026, at the New York Marriott Marquis - Presentation at 9:15 a.m. ET and one-on-one meetings. Webcast details

4 - Claritev Corp (0001793229) (Issuer)

Expanded agreement builds on PHCS network access with pre- and post-payment integrity capabilities spanning the claims lifecycle Claritev Corporation (NYSE:CTEV), a healthcare technology, data, and insights company, today announced that Marpai, Inc. (OTCQX:MRAI) has expanded its relationship with Claritev to bring comprehensive pre- and post-payment integrity capabilities to the health plans and claims it administers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260817677350/en/ Marpai currently uses Claritev’s PHCS® Network to provide access to healthcare providers and negotiated rates outside its clients’ primary networks.

4 - Claritev Corp (0001793229) (Issuer)

4 - Claritev Corp (0001793229) (Issuer)

4 - Claritev Corp (0001793229) (Issuer)

10-Q - Claritev Corp (0001793229) (Filer)

8-K - Claritev Corp (0001793229) (Filer)

Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 Net Loss of $59.2 million Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 2025) Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2026. "Claritev once again demonstrated the strength of our vision and strategy in the second quarter of 2026, delivering financial results above expectations with solid execution across the company. We are one year in

Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will participate in the Canaccord Genuity 46th Annual Growth Conference, being held in Boston, including a fireside chat on Tuesday, August 11, 2026, at 10:00am ET. A live webcast and audio archive of the event will be available through the investor relations section of Claritev’s website at https://investors.claritev.com/news-events/events. About Claritev Claritev is a healthcare technology, data, and insights company focused on delivering affordability,

New CMS data shows Claritev led all non-payer organizations in federal IDR volume while delivering outcomes above industry averages Claritev achieved a 20% IDR success rate versus 12% industrywide, increasing to 24% versus 15% in the fourth quarter Claritev ranked as the market-leading independent non-payer IDR administrator, with volumes exceeded only by the nation’s largest health insurers Claritev Corporation (NYSE:CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that, according to newly released 2025 data from the Centers for Medicare & Medicaid Services (CMS), the Company hand

New solution combines claims-informed intelligence with AI-powered financial guidance to help employees make smarter benefits decisionsMCLEAN, Va. and WALTHAM, Mass., July 28, 2026 /PRNewswire/ -- Claritev Corporation (NYSE:CTEV), a healthcare technology, data, and insights company, and SAVVI Financial, a provider of workplace financial guidance, today announced Claritev Benefit Decision Support, a new solution that helps employers deliver more personalized benefits guidance while empowering employees to make better-informed choices about their healthcare coverage and financial priorities. Many benefit decision support tools still rely on lengthy employee questionnaires, generic assumptions,